How can we understand and define re-challenge in the treatment of mCRC?
How can we understand and define re-challenge in the treatment of mCRC?
Dr. Dominik Modest
Dr. Dominik Modest addresses the clinical question: how can we understand and define re-challenge in the treatment of mCRC?Dr. Dominik Modest
Medical Oncologist
Charité Universitaetsmedizin
Germany
Dr. Dominik Modest has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
| 5 min | 2019
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.